Anemia is associated with the increased risk of cognitive decline and dementia in the general population (Shah et al., 2011) and ESRD patients (Kurella Tamura et al., 2011), which can be improved after anemia treatment with erythropoietin (Hung et al., 2019). Here, EPO is linked to anemia (phenotype).